While most literature demonstrates excellent outcomes in cirrhotic patients, some studies in our review, such as Jacobson I et al. [8], highlighted variability in SVR rates depending on factors such as IL28B genotype and cirrhosis status, which are not universally emphasized in prior reviews. This evidence concerns the gene IFNL3 and Cirrhosis.